Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This company has no revenues since last year...... wonder why it is that low
Even better today - $4 trade and the stock value drops by little over $500,000 - lol (52,622,574 shares OS).
LOL at someone selling 235 shares today at 4 cents.
Needed 9 dollars for a stop at McDonalds???
Silly
Hey guys, happy 4th for you folks south of the border. I am also happy PSC got caught - they are scammers just like HGS - I think I remember someone from PLMO stating that they wanted exposure for the stock but made a mistake using PSC to promote. Glad that is part of our history now.
Anyway, we are due for some goods news and back up we should go. Seemed to have found the bottom here at about 5 cents. I have averaged my way down to just above 10 cents and want to ride this one back up and think it is very possible to see 50 cents again in the next year.
Ciao for now.
Wow, I never heard that about PSC. I guess they had it coming. This company definitely made a mistake by going with them, but they're way beyond that now.
Happy 4th to all
True tho they got busted and shut for good this week so they're no thereat to stocks anymore as their involvement was the kiss
of death to so many. Time to accumulate here :)
They've been gone for the last 8 months. We're awaiting regulatory approval for PulmoBind. The company says that will happen sometime this year. When it does, this party will get started.
Welcome aboard if you choose to join us
Nice to meet you as well. I hope you and Chris and your families are enjoying the holiday.
Kay
This stock was pumped hard by PSC. Now that they're gone maybe it's safe to get back in?
Nice to meet you Kay.
I added you to the list, and look forward to having you around for blastoff.
Thanks for posting. I just got around to seeing this.
At least they're keeping the news coming. Now give us the damn regulatory approval news so we can take off!
News ...
Pulmo BioTech Inc. Has Revealed That Its PulmoBind(TM) Pulmonary Vascular Diagnostic Product Candidate May Have Particular Appli
Date : 06/29/2010 @ 9:00AM
Source : GlobeNewswire Inc.
Stock : Pulmo BioTech Inc. (PLMO)
Quote : 0.065 0.0 (0.00%) @ 9:37AM
Pulmo BioTech Inc. Has Revealed That Its PulmoBind(TM) Pulmonary Vascular Diagnostic Product Candidate May Have Particular Appli
Pulmo Biotech (BB) (OTCBB:PLMO)
Intraday Stock Chart
Today : Tuesday 29 June 2010
"Pulmonary Embolism (PE) is a potentially fatal condition that occurs when a blood clot forms within the vascular system of the body, becoming detached and then lodged in the pulmonary circulatory system of the lungs. Lung tissue death occurs beyond the embolism and depending on the size of the embolism this can result in conditions ranging from shortness of breath to death. There are many different causes for PE, but one of the times that people are most vulnerable is after surgery. The nature of the surgery itself coupled with post-operative care and reduced mobility can potentially contribute to a patient experiencing PE. If the early experimental results of PulmoBind™ are confirmed by further experiments and clinical trials, then PulmoBind™, which is a simple non-invasive diagnostic test, could be of particular benefit to patients who have undergone surgical intervention." – Garry McCann, CEO, Pulmo BioTech Inc.
About Pulmo BioTech Inc.
Pulmo BioTech Inc. (OTCBB:PLMO) (Frankfurt:PB0) specializes in the development and marketing of medical technology and research. Our proven strengths combine extensive commercial experience and academic credentials. The principal staff members are acknowledged experts in their specialized fields, and work with a broad range of investment institutions. Our mission is to utilize scientific imagination and drive, together with managerial and financial acumen, to bring innovative and profitable products to the marketplace to the benefit of all stockholders.
ISIN: US7458451074
CUSIP: 745845107
WKN: A0RDTZ
About PulmoScience Inc.
PulmoScience Inc. was established in 2006, and is currently developing a non-invasive Molecular Imaging technique for the diagnosis of Pulmonary Embolism, Pulmonary Hypertension and Lung Inflammatory diseases under the trade name PulmoBind™.
PulmoScience was conceived within the Montreal Heart Institute "MHI" (a world renowned hospital and educational facility). Jointly owned by MHI subsidiary Innovacor as the technical and operational partner, Dr. Jocelyn Dupuis (the scientific director and originator of the PulmoBind™ Molecular Imaging technology), and by Pulmo BioTech Inc. as the funding partner, PulmoScience Inc. aims to develop this unique and exciting technology, to fund necessary trials, and to bring the products to market.
PulmoScience believes that the market for its product candidates is worth in excess of $500 million per annum and that, provided Regulatory Approval is achieved, the safety and efficacy of its products could allow it to dominate that market.
About PulmoBind™
PulmoBind™ uses an intravenously delivered radionuclide tagged molecule which specifically bonds to the inner walls of the circulatory system in the lungs, and by the use of an external Gamma Camera allows an image of the integrity of the blood vessels throughout the lungs to be seen by a diagnostic clinician. PulmoScience is currently undertaking Regulatory Approval for Phase I Human Trials, and while subsequent results from additional tests might not corroborate the current results, PulmoScience believes that PulmoBind™ has the potential to dominate the market for the diagnosis of Pulmonary Embolism. In particular, this belief is driven by PulmoScience's expectations of the improved safety and efficacy that PulmoBind™ will offer when compared to the current incumbent nuclear medicine based technology for the diagnosis of Pulmonary Embolism. In addition, early indications are that PulmoBind™ could be highly effective in the early stage diagnosis of Pulmonary Hypertension, a condition for which there is no current front line diagnostic test. The addressable market for the product candidates being developed by PulmoScience is believed by the company to be worth in excess of $500 million per annum.
Further Information
For further information regarding Pulmo BioTech Inc. or PulmoScience, please visit www.pulmobiotech.com
Forward-Looking Statements
Forward-looking statements contained in this and other written and oral reports are made based on known events and circumstances at the time of release, and as such, are subject in the future to unforeseen uncertainties and risks. All statements regarding future performance, earnings projections, regulatory approval, events or developments are forward-looking statements. It is possible that the future performance of the company may differ materially from current expectations, depending on economic conditions and the uncertainty of regulatory approval. A change in economic conditions may have a particularly volatile effect on results. Among the other factors which may affect future performance are: competitive market conditions and resulting effects on sales and pricing; increases in raw-material costs that cannot be recovered in product pricing; and global economic factors, including difficulties entering new markets and general economic conditions such as inflation, interest rates and credit availability. The company makes these statements as of the date of this disclosure, and undertakes no obligation to update them.
CONTACT: Pulmo BioTech Inc.
Peter B. Hirshfield
+1-646-827-9362
phirshfield@hirshfieldlaw.com
Hi Ryan,
Sorry not to have posted before but I have been busy with some work issues. I am happy to be an assistant mod but like Chris have not managed posts before but willingly accept the deputies badge Lol. Happy to see you two doing so well in the averaging down race I am well behind but trust I still have time.
Kay
Hey Ryan.
No insight my friend other than what we have seen and read in PR's over the last 6 months or so. The MHI is reputable and hence my reason for sticking around and averaging down.
I am orginally from Ontario, just north of Toronto and about 8 hours west of Montreal. A good old Canadian girl eh, you know how to pick the best Ryan ... good on ya!!
As far as assistant moderator goes, have no clue how to manage posts ect. but with the slow pace of this board, I am AOK with it.
I check Level II periodically through the day (I'm not a day trader, just an invester that monitors his investments closely) so if I see something up, I will throw a post your way to let you know.
Ciao for now.
PS - My name is Chris
I added a grand worth at .40, then added another grand at .30, another grand at .17, and finally the 11,000 shares last week at .5.
Being from Canada, do you have any insight into the company that we might not have ckbaby?
My wife is from the Montreal area, but I imported her and we're in Virginia. I felt confident about buying initially becuase of what she told me about the MHI.
Added you as an Assistant, ckbaby
Now you're not allowed to sell until at least 5.00.
lol
One of these days i'll need help keeping this place from becoming a zoo.
Dawn, let me know that you're still here and I'll add you as well.
By the way, my name is Ryan.
Oops, down to 0.125 I mean ... I wish I was 0.0125!!
Me too, down to 0.0125 after starting a little higher than you NoWhen2HoldEm at about $0.95. Couldn't resist a bunch of 0.052-0.055 over the past month ... I do believe it will eventually pay us back in time.
Well.....
I'm happy to say, that after my initial purchase price of .80, I'm now averaged down to .18 a share.
Regulatory approval is expected sometime this year. Really looking forward to the days when we watch this go back over a dollar.
I honestly do not understand that one bit. 9,500 volume on the day, and someone went that far above the ask to purchase?
Fat fingers???
Check out the small volume spike a few minutes ago NoWhen2HoldEm ... kinda weird.
Ha ... what a jump in price that was ... what's up with that gang?
More News Out Today.....
http://ih.advfn.com/p.php?pid=nmona&article=43119834&symbol=NB%5EPLMO
I broke over today and bought an additional 11,000 shares.
You bet, Dawn. Great to see you in here again. I look forward to the days when we feel like living in here.
Strange, five months is the exact time frame I have in mind,after that $$$'s here we come. Great minds think alike,lol.
Nope, I agree with you completely. Knowing that you lose 15% is much better than 35%, so having it hold steady for the next 5 months wouldnt bother me, either.
A gentle breeze carrying a scent of promise from the horizon. On a more prosaic note it would suit me if this held steady for a couple more months. Sorry I know I’m being selfish, lol
News Out Today....
Nothing substancial, but it sure was nice to hear from them after a six month quiet period.
http://ih.advfn.com/p.php?pid=nmona&article=42945841&symbol=NB%5EPLMO
Averaged down another 15,000 shares today. I have a feeling we are going to 'pop' here one day ...
Still only retail sellers ... need time but what is waiting another 6 months if I have waited this long eh!!
Wow,
Excellent info ck, thank you. I'm hoping to add some more tomorrow. Was away from the computer all day today.
Right...
And a 50,000 share buy at the bell. Man, I really don't have the funds to sink another grand (ok, i kinda do) right now, but something tells me I honestly should give it some thought.
Another interesting day ... more volume, more price appreciation, somethings seems to be brewing.
Tons of volume compared to what we've seen over the past few months.
That's why I think news may be coming down in the near future.
Good to see you'll hang around until at least .50 ckbaby. I won't sell any of mine until a buyout happens, which, undoubtedly, will bring investors multiple dollars per share.
Let's just hope that the wheels are beginning to turn here.....
I see we are waking up again today everyone ... any news that I am not aware of?
Being adding at 0.05 level to average down and looks like that might have just paid off. Holding until at least 0.50 as a little bit of volume will drive us back to those levels IMO.
Really nice buy (25,000) today on no news whatsoever. Let's hope something from the company could be coming soon.
Guys, I'm with you as well. Hold a signficant position and actually plan to continue to average down a bit more over the next while. I do believe we will be coming back to life in the not to distant future and I want to take advantage of some retail traders (under NITE) giving away some discount shares.
Good to see you moderate for us NoWhen2HoldEm ... I look forward to days ahead as well.
ckbaby
Thank you very much.
Looking forward to the days where we take off and enjoy each others company in here on a daily basis.
Hi,NW2HE great news, the sheriffs in town.It maybe a ghost town now but given the potential of this company ...... Thanks for contacting Peter Hirschfeld.GLTA
Just so you guys know, I went ahead and took the Moderator job. Some day soon we'll have a stock worth bashing, and I'm just the guy to have no tolerance for it.
Keep us informed if you get anything back NoWhen2HoldEm.
Who I'd really like to speak to is Dr. Dupuis. That's where the real information is. I wrote an email a month or two ago and got no response.
My wife spent her entire life in the Montreal area before moving here to the states with me. We'll be heading back there in June, and I'm hoping to make a trip to the MHI while we're there.
Hirshfields response back to me was lightening quick. He's a lawyer, so we'll never be able to get much out of him, but at least someone from the company said something.
Nothing substancial here at all, but I thought I would share a conversation I had with PLMO Secretary(Attorney), Peter Hirshfield:
Mr. Hirshfield,
My name is Ryan XXXXXX. I hold a substancial stake in Pulmo-Biotech, or PLMO.
As you may know, there has been no communication from the company to investors since December of 2009.
I have been a big believer in this company and its product. However, the lack of any communication has been disheartening lately.
Since it seems that Mr. McCann and Dr. Dupuis do not intend to return my emails, I am hoping that you will afford me the courtesy of a response, and am hoping you'll be able to tell me how things with the company may or may not be progressing, to the limit that the law allows you, of course.
Thank you, sir, and I hope to hear from you in return.
Subject: RE: Mr. Hirshfield
Date Received: 4/7/2010 3:31:00 PM
Date Sent: Wed, 7 Apr 2010 15:30:38 -0400
Priority: Normal
From: "Peter B. Hirshfield" <phirshfield@nyc.rr.com>
To: XXXXX
CC:
Show Header Show Raw Message
Dear Mr. XXXXX,
Pulmo BioTech has always had a policy of disclosing material developments by way of press release and/or public filings on the SEC ERGAR site. As you may know, Regulation FD prohibits a company whose shares trade publicly from making selective disclosure to some without immediately disclosing the same to everyone. As the Company does not have any material developments to report at this time, it is complying with its periodic reporting on the EDGAR site but not making any press releases. This policy will continue until Pulmo BioTech believes that material developments have occurred, which require a press release. I refer you to the following hyperlink, which is the Pulmo BioTech page on the SEC EDGAR website. You should take comfort in knowing that the filings referred to on that page tell everything about Pulmo BioTech that is ripe for public disclosure. http://www.sec.gov/cgi-bin/browse-edgar?company=Pulmo+BioTech&match=&CIK=&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany
Best regards,
Peter B. Hirshfield
Hirshfield Law
1035 Park Avenue
Suite 7B
New York NY 10028-0912
T: (646) 827-9362
F: (646) 349-1665
W. www.hirshfieldlaw.com
Thanks for posting NoWhen2HoldEm. In the exact boat as you and will be watching over time as well.
Thanks and well chat later.
I'm here with you guys for the long-haul, just havent had much to say as the company lays low for a bit while human trials go on.
The "PLMOE" tag was due to the company not reporting enough information. The OTCBB gave them 30 days to provide the information, or it would be dropped from the exchange.
Was very glad to see the company provided the info. In this time where we're not hearing anything from them, it was good to see. They have to realize they made a big mistake by enlisting PSC for help. Staying quiet right now, IMO, is a good move.
I expect the next time we hear from them, for it to be substancial news. Regulatory approval information should be coming soon as well.
Like some of you, I bought-in way too high with the PSC campaign. Since that time, and because I truly believe this company will be a big success, I've sunk considerably more into the stock and averaged down to .28
No rush for me, as it won't be a year that I've held the stock until October and November of this year.
In my research that I've done, I feel the best way now to get ahold of someone associated with the company is through Peter Hirschfeld, the attorney.
Wouldn't be a bad idea to contact him if one of you felt froggy.
Take care, and I'll be checking-in with you guys when I can.
Hi all,
is anyone so gently to share his/her DD with my about PLMO.
Going to make my one.
Any others view is appreciated!
thank you
Cheche
Fortune favours the bold, brave and INDOMITABLE. Come mid April and I’m going to contact IR and find out what’s happening. There may be others out there on more distant planets presently hiding under rocks as the year goes on maybe they can be tempted out or more appropriately IN. Until then wishing you and yours a great Easter.
Well Dawn, it looks like it is just you and I. I have a hell of a long way to go as well but there appears to be life again!!
Followers
|
6
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
228
|
Created
|
10/21/09
|
Type
|
Free
|
Moderators |
Welcome to Pulmo Biotech | | ||
About Us | |||
Our Partners | |||
Products | |||
Investor Relations | |||
Press | |||
Contact Us | |||
| |||
iBox by JMoola |
PulmoBioTech is a publically listed company which trades on the NASDAQ OTC (symbol PLMO).
Garry McCann, Director & CEO
Garry, age 49, is also the Managing Director of MC&C td, a UK business consulting company. Prior to these positions he was the Managing Director of NE Technology Ltd, a global leader in the design and manufacture of radiation detection equipment. Garry has also been active in the fields of CAT X-ray generators, medical imaging CCDs and IR Image Sensors. Garry has an MBA from Warwick University Business School and a BSc in Physics from the University of Surrey.
Company Secretary
Peter B. Hirshfield
+1-646-827-9362
phirshfield@hirshfieldlaw.com
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |